PR NEWSWIRE

immediapress comunicato stampa

Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia

BASEL, Switzerland and LINCOLNSHIRE, Il., Dec. 2, 2025 /PRNewswire/ -- Vaderis Therapeutics today announced that data from its randomized, double-blind, placebo-controlled, multi-center proof-of-concept study and long-term extension of engasertib (VAD044) in Hereditary Hemorrhagic Telangiectasia (HHT...

immediapress comunicato stampa

Sedus chiede: "In ufficio c'è un problema di concentrazione?"

DOGERN, Germania, 2 dicembre 2025 /PRNewswire/ -- Viviamo in un mondo che richiede la nostra costante attenzione. Ogni gesto, ogni schermo, ogni suono è progettato per distrarci. Le continue notifiche delle app, i telefoni che squillano o i colleghi che parlano a voce troppo alta ci rubano tempo prez...

immediapress comunicato stampa

GAC launches AION V in Greece

ATHENS, Greece, Dec. 2, 2025 /PRNewswire/ -- Today, GAC officially launched its electric SUV, the AION V, in Greece. After Finland, Poland and Portugal, Greece is the fourth European market to welcome GAC vehicles. This step increases the footprint of high-quality electric vehicles in the Southern re...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza